DEA Extends COVID-19 Telemedicine Flexibilities Through December 31, 2025

DEA Extends COVID-19 Telemedicine Flexibilities Through December 31, 2025

The Drug Enforcement Agency (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) jointly issued a third temporary rule that extends the full set of COVID-19 telemedicine flexibilities for prescription of controlled medications through December 31, 2025. What is it. The agencies note that as the DEA and the Department of Health and Human Services (HHS) continue to… (Marceno, November 15, 2024) #Opioids, #Telehealth